These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10934733)

  • 21. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SYNTHESIS AND IN VITRO CHARACTERIZATION OF HYDROXYPROPYL METHYLCELLULOSE-GRAFT-POLY (ACRYLIC ACID/2-ACRYLAMIDO-2-METHYL-1-PROPANESULFONIC ACID) POLYMERIC NETWORK FOR CONTROLLED RELEASE OF CAPTOPRIL.
    Furqan Muhammad I; Mahmood A; Aysha R
    Acta Pol Pharm; 2016; 73(1):183-96. PubMed ID: 27008813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
    Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sodium bicarbonate and sodium starch glycolate on the in vivo disintegration of hard gelatin capsules--a radiological study in the dog.
    Marvola M; Hannula AM; Ojantakanen S; Westermarck E; Rajamäki M
    Acta Pharm Nord; 1989; 1(6):355-62. PubMed ID: 2560378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug release from compressed hydrophilic POLYOX-WSR tablets.
    Kim CJ
    J Pharm Sci; 1995 Mar; 84(3):303-6. PubMed ID: 7616368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel combinations of rate-controlling polymers for the release of leuprolide acetate in the colon.
    Prabhu S; Kanthamneni N; Ma C
    Drug Deliv; 2008 Feb; 15(2):119-25. PubMed ID: 18293198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric microcontainers improve oral bioavailability of furosemide.
    Nielsen LH; Melero A; Keller SS; Jacobsen J; Garrigues T; Rades T; Müllertz A; Boisen A
    Int J Pharm; 2016 May; 504(1-2):98-109. PubMed ID: 27033999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
    Elkheshen SA; Radwan MA
    J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice.
    Lin YK; Ho HO
    J Control Release; 2003 Apr; 89(1):57-69. PubMed ID: 12695063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Process and formulation variables affecting the performance of a rupturable capsule-based drug delivery system with pulsatile drug release.
    Dashevsky A; Bussemer T; Mohamad A; Bodmeier R
    Drug Dev Ind Pharm; 2004 Feb; 30(2):171-9. PubMed ID: 15089051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid fill hard gelatin capsules.
    Rowley G; Hawley AR; Dobson CL; Chatham S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):605-11. PubMed ID: 9876504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid/Hollow depots for drug delivery, part 1: effect of drug characteristics and polymer molecular weight on the phase-inversion dynamics, depot morphology, and drug release.
    Liu H; Venkatraman SS
    J Pharm Sci; 2014 Feb; 103(2):485-95. PubMed ID: 24357252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
    Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
    J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injection-molded capsule bodies and caps based on polymer blends for controlled drug delivery.
    Benzine Y; Siepmann F; Neut C; Danede F; Francois Willart J; Siepmann J; Karrout Y
    Eur J Pharm Biopharm; 2021 Nov; 168():1-14. PubMed ID: 34438018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.
    Kim CJ
    Drug Dev Ind Pharm; 1998 Jul; 24(7):645-51. PubMed ID: 9876509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.